Historical record - last NADAC effective date: 2/21/2024

Product Information

AMLODIPINE BESYLATE 2.5 MG TAB is a generic product labeled by Cipla USA Inc., priced at $0.0163 per EA under NDC 69097083605. Its NADAC has been published 385 times since Oct 12, 2016.

FDA first approved this application on Aug 28, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMLODIPINE BESYLATE 2.5 MG TAB

Amlodipine Besylate
$0.0163per EA

Strength

2.5 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097083605

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

2/21/2024

Active Ingredients

AMLODIPINE BESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA077955

FDA Approved

8/28/2007

TE Code

AB

On Market Since

7/1/2016

Pharmacological Classes

Calcium Channel Antagonists
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for AMLODIPINE BESYLATE 2.5 MG TAB has been published 385 times since Oct 12, 2016, and over the history we have for it it has declined 18.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0163 per EA
All-time high$0.0206 (Nov 16, 2016)
All-time low$0.0113 (Jun 22, 2022)
Median price$0.0158
Average price$0.0155
Largest weekly change+24.6% (Jan 17, 2018)
Weeks tracked385
Tracking sinceOct 12, 2016

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

+20.6%

5Y

+28.7%

All

-18.9%

Last surveyed Feb 21, 2024 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 37% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of AMLODIPINE BESYLATE 2.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE BESYLATE 2.5 MG TAB, manufactured by Cipla USA Inc., is $0.0163 per EA (NDC 69097083605), effective Feb 21, 2024.

How has the price of AMLODIPINE BESYLATE 2.5 MG TAB changed over time?

Over the history we have for it, the NADAC for AMLODIPINE BESYLATE 2.5 MG TAB has declined 18.9%. It has been tracked across 385 weekly CMS publications since Oct 12, 2016.

What are the highest and lowest recorded NADAC prices for AMLODIPINE BESYLATE 2.5 MG TAB?

Since Oct 12, 2016, the NADAC for AMLODIPINE BESYLATE 2.5 MG TAB has ranged from a low of $0.0113 (Jun 22, 2022) to a high of $0.0206 (Nov 16, 2016), with a median of $0.0158 per EA.

Are there cheaper alternatives to AMLODIPINE BESYLATE 2.5 MG TAB?

Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMLODIPINE BESYLATE 2.5 MG TAB, is $0.0103 per EA — about 37% below AMLODIPINE BESYLATE 2.5 MG TAB.

Who manufactures AMLODIPINE BESYLATE 2.5 MG TAB?

AMLODIPINE BESYLATE 2.5 MG TAB (NDC 69097083605) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.